Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Formin-binding protein 1-like (FNBP1L) is an adaptor protein that contains an F-BAR domain and functions to connect membrane curvature with the assembly of the actin cytoskeleton and membrane trafficking. It binds to CDC42 and N-WASP, promoting CDC42-induced actin polymerization by activating the N-WASP-WIP complex, and links cell surface signals to actin cytoskeleton changes. FNBP1L is essential for xenophagic autophagy—specifically, it helps clear intracellular bacteria by organizing autophagy machinery at sites of pathogen entry, restricting microbial proliferation. It is notably important for pathogen-induced autophagy but is dispensable for non-infectious autophagy conditions. FNBP1L is also involved in coordinating membrane tubulation and the formation of endocytic vesicles during endocytosis, and may bind to phosphatidylinositol 4,5-bisphosphate and phosphatidylserine. While FNBP1L is implicated in cell biology processes relevant to disease (such as neurodegeneration and infection), there are no approved drug interactions or established mechanisms of action for therapeutic targeting as of current knowledge. No recognized clinical biomarkers or safety concerns uniquely attributable to FNBP1L are documented in the reviewed sources. While not a classical receptor, enzyme, or transporter, FNBP1L is a molecular scaffold/adaptor protein important in cell signaling and cytoskeletal dynamics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Formin-binding protein 1-like (FNBP1L).